搜索医生

Evanthia Galanis, M.D.

  1. Oncologist
预约门诊

科室

专业团队

地点

  1. Rochester, Minnesota

语言

English

现有患者

就诊

  1. 507-512-8186
  2. 在线申请就诊
  1. 1998
    FellowshipHematology/Oncology, Programs in Rochester, Mayo School of Graduate Medical Education, Mayo Clinic College of Medicine
  2. 1998
    ResidentHematology/Oncology, Programs in Rochester, Mayo School of Graduate Medical Education, Mayo Clinic College of Medicine
  3. 1998
    Fellow - Hematology/OncologyMayo Graduate School of Medicine, Mayo Clinic College of Medicine
  4. 1994
    ResidentInternal Medicine, Programs in Rochester, Mayo School of Graduate Medical Education, Mayo Clinic College of Medicine
  5. 1993
    D.Sc - ""Development and application of quantitative immunoenzymatic assays (ELISAS) and immunoblotting techniques in the study of specificity and title of M1- antimitochondrial antibodies (M2-AMA).Athens University School of Medicine, Athens
  6. 1990
    MDAthens University School of Medicine, Athens

Certifications

  1. 1997
    Medical OncologyAmerican Board of Internal Medicine

Awards and honors

  1. 2023
    Victor Levin Award for Achievement in Neuro-OncologyThe Society for Neuro-Oncology
  2. 2023
    Professor Honoris CausaNational and Kapodistrian University of Athens
  3. 2020
    Distinguished Mayo Clinic Investigator AwardMayo Clinic
  4. 2013
    Sandra J. Schulze ProfessorshipSandra J. Schulze Professorship
  5. 2011
    Elected MemberAmerican Society of Clinical Investigation
  6. 2005
    Award of Excellence13th International Conference on Gene Therapy
  7. 1998
    AACR/Glaxo Wellcome AwardAmerican Association for Cancer Research
  8. 1998
    Outstanding Achievement Award in OncologyMayo Clinic
  9. 1997
    Award on Genetics in OncologyBerlex Oncology Foundation
  10. 1997
    Award on Clinical Pharmacology of Anticancer DrugsBerlex Oncology Foundation
  11. 1997
    Linse-Bock Fellowship in Neuro-OncologyAwarding Organization
  12. 1997
    AACR ScholarshipAACR Molecular Biology Workshop
  13. 1996
    Award on Epidemiology and Clinical Trial DesignBerlex Oncology Foundation
  14. 1994
    Internal Medicine Outstanding Research AwardMayo Graduate School of Medicine, Mayo Clinic College of Medicine and Science, Department of Education Administration
  15. 1990
    ValedictorianUniversity of Athens Medical School
  16. 1990
    Scholarship for Completion of D.Sc ThesisGreek Ministry of Public Health
  17. 1984
    Yearly ScholarshipsGreek Ministry of Education/National Scholarship Foundation

Professional memberships

  1. 2025
    MemberAmerican Society of Gene and Cell Therapy, Advancing Cell and Gene Therapies for Cancer Planning Committee
  2. 2025 - present
    2025 Scientific Committee Member, CNS Tumours TrackEuropean Society for Medical Oncology
  3. 2024 - present
    Chair, External Advisory Board of Yale Brain Tumor SPOREYale University
  4. 2023 - present
    PresidentAlliance for Clinical Trials in Oncology Foundation
  5. 2023 - present
    Group ChairAlliance for Clinical Trials in Oncology
  6. 2023 - present
    2023 Scientific Committee Member, CNS Tumours TrackEuropean Society for Medical Oncology
  7. 2022 - 2023
    MemberBold. Forward. Unbound. in Rochester Advisory Group, Clinical Practice Committee, Mayo Clinic Rochester Executive Operations Team
  8. 2021 - present
    Co-chair, National ConferenceAmerican Brain Tumor Association
  9. 2021 - 2022
    IOVC Organizing Committee, MemberAmerican Society of Gene and Cell Therapy
  10. 2021 - present
    MemberEuropean Organisation for Research and Treatment of Cancer, Protocol Review Committee
  11. 2021 - present
    Lead, CNS TrackAmerican Society of Clinical Oncology, ASCO Scientific Program Committee
  12. 2020 - present
    MemberMayo Clinic Proceedings Business Advisory Board
  13. 2020 - present
    Chair, External Advisory CommitteeDana Farber, Harvard Cancer Center, K12 Training Grant in NeuroOncology
  14. 2020 - present
    Co-Chair, Awards CommitteeSociety for Neuro-Oncology
  15. 2019 - 2023
    ConsultantCellular, Tissue and Gene Therapies Advisory Committee, Food and Drug Administration
  16. 2019 - 2023
    ConsultantCellular, Tissue and Gene Therapies Advisory Committee, Food and Drug Administration
  17. 2019
    IOVC Organizing Committee, MemberAmerican Society of Gene and Cell Therapy
  18. 2019 - present
    MemberMedical Industry Relations Committee, Mayo Clinic Rochester Committees
  19. 2019 - present
    Lead, CNS TrackAmerican Society of Clinical Oncology, ASCO Scientific Program Committee
  20. 2018 - present
    Co-Leader, Brain Cancer InitiativeNational Cancer Institute, Food and Drug Administration, Novel Therapeutics Working Group
  21. 2018
    ChairDevelopmental Therapeutics Study Section, NCI Study Sections
  22. 2018 - present
    MemberMayo Clinic Research Committee, Mayo Clinic Committees
  23. 2018 - present
    Program Committee MemberAnnual Meeting Scientific Program Committee, American Society of Clinical Oncology
  24. 2017 - present
    MemberExecutive Committee, Virus and Gene Therapy Program, Mayo Graduate School; Virus and Gene Therapy Program; Executive Committee
  25. 2017 - present
    MemberMayo Extramural Research Partnership (MERP) Executive Office
  26. 2017 - present
    Industry Arm LeaderMayo Extramural Research Partnership (MERP) Executive Office
  27. 2017 - 2025
    Board MemberNational Brain Tumor Society
  28. 2016 - 2017
    ChairMayo Clinic Committees, Recruitment Package Task Force
  29. 2016 - 2017
    Co-ChairT-VEC (Talimogene Laherparepvec) Project Team, National Cancer Institute, National Institutes of Health
  30. 2016 - present
    MemberNamed Professorship Committee - Mayo Clinic, Mayo Clinic Committees
  31. 2016 - 2022
    MemberNamed Professorship Committee - Mayo Clinic, Mayo Clinic Committees
  32. 2016 - 2017
    MemberAmerican Society of Clinical Oncology, Clinical Practice Guideline Panel for Radiation Therapy for Glioblastoma
  33. 2015 - present
    MemberClinical Outcome Assessment Messaging Working Group, National Brain Tumor Association
  34. 2015 - present
    MemberMayo Clinic Hepatobiliary SPORE, Internal Scientific Advisory Committee
  35. 2015 - 2017
    MemberT-VEC (Talimogene Laherparepvec) Project Team, National Cancer Institute, National Institutes of Health
  36. 2015 - present
    Co-ChairNational Institutes of Health, National Cancer Institute, Glioblastoma/Brain Metastases Interest Group
  37. 2014 - present
    MemberMayo Clinic SPORE in Pancreatic Cancer, Internal Scientific Advisory Committee
  38. 2014 - 2015
    MemberClinical Outcome Assessment Endpoints Workshop, National Brain Tumor Association
  39. 2014 - present
    MemberBrain Tumor Imaging Standardization Steering Committee, National Brain Tumor Association
  40. 2013 - 2015
    MemberSociety for Neuro-Oncology, Executive Committee
  41. 2013 - 2015
    Secretary/TreasurerSociety for Neuro-Oncology
  42. 2013 - present
    MemberMayo Clinic Scientific Advisory Council, Mayo Clinic Research Committee, Mayo Clinic Committees
  43. 2013 - present
    MemberAdvisory Council to the Executive Dean for Research, Mayo Clinic Committees
  44. 2013 - present
    MemberTranslational Oversight Group, Center for Regenerative Medicine, Mayo Clinic Committees
  45. 2013 - 2023
    Abstract ReviewerAnnual Meeting, Society for Neuro-Oncology
  46. 2013 - 2019
    Charter MemberDevelopmental Therapeutics Study Section, NCI Study Sections
  47. 2013 - 2017
    US LeadRare Brain Tumour Group, International Rare Cancer Initiative
  48. 2013
    ChairAmerican Society of Gene and Cell Therapy, Targeted Cancer Gene and Cell Therapy Abstract Review Committee
  49. 2011 - present
    External Advisory Board MemberMD Anderson Cancer Center, Brain SPORE
  50. 2011 - 2019
    Abstract ReviewerAmerican Society of Gene and Cell Therapy
  51. 2011 - 2020
    Program LeaderMayo Clinic Cancer Center, Mayo Clinic Cancer Center - Rochester, Gene and Virus Therapy Program
  52. 2011 - 2023
    ChairNeuro-Oncology Committee, Alliance for Clinical Trials in Oncology
  53. 2011 - 2018
    MemberCancer Gene & Cell Therapy Committee, American Society of Gene and Cell Therapy
  54. 2011 - present
    MemberAlliance for Clinical Trials in Oncology
  55. 2011 - present
    Elected MemberAmerican Society of Clinical Investigation
  56. 2010
    ChairSite Visit Team, Food and Drug Administration
  57. 2010 - 2024
    MemberBrain Malignancies Steering Committee, National Cancer Institute, National Institutes of Health
  58. 2010
    MemberSite Visit Team, Food and Drug Administration
  59. 2009 - 2011
    MemberInternal Scientific Advisory Committee, Mayo Clinic Breast SPORE, Mayo Clinic Cancer Center
  60. 2009 - 2015
    ConsultantCellular, Tissue and Gene Therapies Advisory Committee, Food and Drug Administration
  61. 2009 - present
    Scientific ReviewerEuropean Research Council
  62. 2009 - 2011
    MemberSociety for Neuro-Oncology, Medical Oncology Representative, Board of Directors
  63. 2009 - 2011
    Co-ChairNeuro-Oncology Committee, North Central Cancer Treatment Group
  64. 2008 - present
    MemberResponse Assessment in Neurooncology Working Group
  65. 2007 - present
    Full MemberMayo Clinic Center for Translational Science Activities
  66. 2007
    Vice ChairResearch Resources Review Committee, Mayo Clinic Center for Translational Science Activities
  67. 2007
    ChairClinical and Experimental Therapeutics #2, United States Department of Defense
  68. 2007 - present
    MemberAcademic Affairs Committee, Mayo Clinic Center for Translational Science Activities
  69. 2005 - 2010
    MemberCTEP Concept Review Committee, National Cancer Institute, National Institutes of Health
  70. 2005 - 2006
    MemberClinical Research Subcommittee, Mayo Clinic Committees
  71. 2004 - 2006
    Advisory Board MemberGeneral Clinical Research Center Advisory Committee, Mayo Clinic Committees
  72. 2004 - present
    MemberInternational Working Group for Gene Therapy
  73. 2003
    MemberCancer Center Site Visit Audit Team, National Cancer Institute, National Institutes of Health
  74. 2002 - 2008
    Vice ChairNeuro-Oncology Committee, North Central Cancer Treatment Group
  75. 2000 - 2005
    Review Panel MemberClinical and Experimental Therapeutics #4, United States Department of Defense
  76. 2000 - 2002
    MemberHematology/Oncology Fellowship Selection Committee, Department of Oncology
  77. 2000 - 2001
    MemberEducation Committee, Division of Medical Oncology, Department of Oncology
  78. 2000 - 2001
    MemberGene Therapy Committee, Greek Ministry of Health
  79. 2000 - present
    MemberResearch Committee, Division of Medical Oncology, Department of Oncology
  80. 1999 - 2011
    MemberNovel Therapeutics Committee, North Central Cancer Treatment Group
  81. 1999 - present
    MemberSociety for Neuro-Oncology
  82. 1998 - 2008
    MemberOncology Review Committee (Previously, Protocol Review Committee), Mayo Clinic Cancer Center Committees, Mayo Clinic Cancer Center
  83. 1998 - present
    MemberNorth Central Cancer Treatment Group
  84. 1997 - present
    MemberAmerican Society of Gene and Cell Therapy
  85. 1996 - present
    MemberAmerican Association for Cancer Research
  86. 1996 - present
    MemberEuropean Association for Cancer Research
  87. 1996 - present
    MemberAmerican Society of Clinical Oncology
  88. 1996 - present
    MemberEuropean Society for Medical Oncology
  89. 1995 - 1998
    MemberAmerican College of Physicians
  90. 1994 - present
    Mayo Clinic Alumni Association, Mayo Clinic College of Medicine and Science, Department of Education Administration
  91. 1993 - present
    MemberHospital Albert Schweitzer Alumni Association
  92. 1991 - 1998
    MemberAmerican Medical Association
  93. 1990 - present
    MemberAthens Medical Association
  94.  
    MemberMayo Clinic Cancer Center - Rochester, Mayo Clinic Cancer Center

Publications

Research activities

See a description of research activities.